Examples of using Open-label study in English and their translations into Swedish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
-
Political
consistency with Eslicarbazepine acetate pharmacology and data from open-label study phases and post-marketing safety data.
randomised, open-label Study 1007.
a single group open-label study(Study GS-US-236-0123) n 910; 628 receiving Stribild.
randomised, open-label Study 1014.
Therefore the studies were performed as open-label studies.
In open-label studies, doses up to 15,000 U were given to patients at intervals of not less than 12 weeks.
There are limited safety data from open-label studies in children from 1 month to< 16 years of age.
This includes data from two placebo-controlled studies, three open-label studies, three compassionate-use subjects and postmarketing reports.
In controlled and open-label studies in adults with vedolizumab, serious infections have been reported,
In earlier, open-label studies, median platelet count reductions were observed in 7 children
In two open-label studies BeneFIX was found to be safely administered at 100 IU/kg once-weekly.
Two randomised, open-label studies were conducted to evaluate the efficacy
Twenty-three malignancies were reported in plaque psoriasis patients treated with Enbrel in double-blind and open-label studies of up to 15 months involving 1,261 Enbrel-treated patients.
Efficacy rates from open-label studies of Ivermectin for the treatment of classic scabies range from 76% to 100%.
Uncontrolled open-label studies suggest sustained long-term efficacy, although no controlled
However, patients completing STRIDE-2 were eligible to enrol in open-label studies STRIDE-2X and STRIDE-3.
refractory multiple myeloma was demonstrated in two open-label studies.
The effect of multiple doses of Arzerra on the QTc interval was evaluated in a pooled analysis of three open-label studies in patients with CLL N=85.
The majority of the adverse reactions of increased CPK observed in all double-blind and open-label studies resolved and were considered mild in severity.
In two large, open-label studies, 2697 cancer patients receiving non-platinum chemotherapy were included, 1895 with solid tumours(683 breast,